- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder ; volume:15 ; number:1 ; day:27 ; month:4 ; year:2018 ; pages:1-9 ; date:12.2018
Journal of neuroinflammation ; 15, Heft 1 (27.4.2018), 1-9, 12.2018
- Creator
-
Yamashita, Kazuya
- Contributor
-
Kinoshita, Makoto
Miyamoto, Katsuichi
Namba, Akiko
Shimizu, Mikito
Koda, Toru
Sugimoto, Tomoyuki
Mori, Yuki
Yoshioka, Yoshichika
Nakatsuji, Yuji
Kumanogoh, Atsushi
Kusunoki, Susumu
Mochizuki, Hideki
Okuno, Tatsusada
SpringerLink (Online service)
- DOI
-
10.1186/s12974-018-1162-0
- URN
-
urn:nbn:de:101:1-2018070116233913221388
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yamashita, Kazuya
- Kinoshita, Makoto
- Miyamoto, Katsuichi
- Namba, Akiko
- Shimizu, Mikito
- Koda, Toru
- Sugimoto, Tomoyuki
- Mori, Yuki
- Yoshioka, Yoshichika
- Nakatsuji, Yuji
- Kumanogoh, Atsushi
- Kusunoki, Susumu
- Mochizuki, Hideki
- Okuno, Tatsusada
- SpringerLink (Online service)
Other Objects (12)
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Emerging treatments for neuromyelitis optica spectrum disorder
Late Onset of Neuromyelitis Optica Spectrum Disorders
Neuromyelitis optica
Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience
Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica
Screening for onconeural antibodies in neuromyelitis optica spectrum disorders
Unveiling the retinal secrets of neuromyelitis optica spectrum disorder
Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders
Neuromyelitis optica spectrum disorders without and with autoimmune diseases
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Emerging treatments for neuromyelitis optica spectrum disorder
Late Onset of Neuromyelitis Optica Spectrum Disorders
Neuromyelitis optica
Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience
Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica
Screening for onconeural antibodies in neuromyelitis optica spectrum disorders
Unveiling the retinal secrets of neuromyelitis optica spectrum disorder
Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders
Neuromyelitis optica spectrum disorders without and with autoimmune diseases
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
Emerging treatments for neuromyelitis optica spectrum disorder
Late Onset of Neuromyelitis Optica Spectrum Disorders
Neuromyelitis optica
Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder
Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience
Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica
Screening for onconeural antibodies in neuromyelitis optica spectrum disorders
Unveiling the retinal secrets of neuromyelitis optica spectrum disorder
Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders